(Q37564261)

21 August 2017

1 reference

title

Generating memory with vaccination (English)

1 reference

21 August 2017

4

Rino Rappuoli

1 reference

21 August 2017

Flora Castellino

1

1 reference

21 August 2017

Grazia Galli

series ordinal

2

1 reference

21 August 2017

Giuseppe Del Giudice

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

European Journal of Immunology

21 August 2017

1 reference

21 August 2017

39

1 reference

21 August 2017

2100-2105

1 reference

21 August 2017

8

1 reference

Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination

21 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

Pattern recognition receptors and control of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Cooperation between CD4+ and CD8+ T cells: when, where, and how.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Germinal-center organization and cellular dynamics

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Antigen-specific interaction between T and B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Duration of humoral immunity to common viral and vaccine antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Duration of antiviral immunity after smallpox vaccination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Migration, maintenance and recall of memory T cells in peripheral tissues

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Complement evasion by human pathogens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Long-term protection in children with meningococcal C conjugate vaccination: lessons learned

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Innate immunity of the newborn: basic mechanisms and clinical correlates

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Current status and progress of prepandemic and pandemic influenza vaccine development.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Molecular and cellular signatures of human vaccine adjuvants.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Malaria vaccine: the latest news from RTS,S/AS01E vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939550

7 January 2021

Identifiers

DOI

10.1002/EJI.200939550

1 reference

21 August 2017

1 reference